HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eva Kimby Selected Research
Eva Kimby Research Topics
Disease
32
Lymphoma (Lymphomas)
06/2023 - 11/2002
26
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2023 - 11/2002
22
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 08/2002
19
Neoplasms (Cancer)
01/2023 - 11/2002
13
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 11/2005
11
Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2021 - 04/2002
10
Waldenstrom Macroglobulinemia (Macroglobulinemia)
10/2023 - 05/2001
6
B-Cell Lymphoma (Lymphoma, B Cell)
06/2023 - 10/2005
6
Infections
10/2022 - 09/2005
6
Neutropenia
05/2021 - 10/2005
3
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2023 - 12/2019
2
Disease Progression
10/2022 - 10/2018
2
Inflammation (Inflammations)
05/2021 - 10/2018
2
Hematologic Neoplasms (Hematological Malignancy)
01/2017 - 01/2006
2
Multiple Myeloma
01/2016 - 01/2016
2
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2016 - 08/2014
2
Pathologic Complete Response
05/2014 - 06/2010
2
Opportunistic Infections (Opportunistic Infection)
04/2013 - 10/2005
2
Splenomegaly
09/2010 - 09/2006
2
Febrile Neutropenia
01/2008 - 04/2006
1
Residual Neoplasm
03/2017
1
Exanthema (Rash)
01/2017
1
Herpes Zoster
01/2017
1
Hodgkin Disease (Hodgkin's Disease)
01/2016
1
Cytopenia
08/2014
1
Trisomy (Trisomies)
05/2014
1
Leukemia
12/2013
1
Bronchiolitis Obliterans Syndrome
12/2013
1
Lymphopenia (Lymphocytopenia)
04/2013
1
Lymphocytosis
05/2012
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2011
1
Lymphadenopathy
09/2010
Drug/Important Bio-Agent (IBA)
31
Rituximab (Mabthera)
FDA Link
10/2023 - 04/2002
8
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2023 - 09/2005
8
Monoclonal Antibodies
IBA
01/2017 - 04/2002
6
Immunoglobulin M (IgM)
IBA
01/2023 - 04/2003
6
Alemtuzumab (Campath)
FDA Link
05/2014 - 08/2002
5
Biomarkers (Surrogate Marker)
IBA
06/2023 - 01/2017
4
fludarabine
IBA
01/2019 - 04/2006
4
Messenger RNA (mRNA)
IBA
01/2014 - 11/2005
3
Conjugate Vaccines
IBA
01/2023 - 02/2012
3
Cytokines
IBA
05/2021 - 01/2005
3
Chlorambucil (Leukeran)
FDA Link
01/2019 - 11/2002
3
Lenalidomide (CC 5013)
FDA Link
01/2019 - 03/2012
3
Ligands
IBA
01/2019 - 12/2005
3
Vaccines
IBA
01/2018 - 02/2012
3
Vincristine (Oncovin)
FDA Link
Generic
01/2017 - 05/2010
3
Prednisone (Sone)
FDA Link
Generic
01/2017 - 05/2010
3
Cannabinoid Receptors (Cannabinoid Receptor)
IBA
01/2014 - 12/2005
3
Proteins (Proteins, Gene)
FDA Link
11/2005 - 04/2003
2
RNA (Ribonucleic Acid)
IBA
12/2023 - 10/2018
2
Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)
IBA
01/2023 - 01/2018
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
05/2021 - 01/2008
2
Bendamustine Hydrochloride
FDA Link
02/2017 - 01/2016
2
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2017 - 05/2010
2
Cytarabine (Cytosar-U)
FDA Link
Generic
11/2016 - 05/2014
2
Immunoglobulins (Immunoglobulin)
IBA
09/2016 - 01/2016
2
ofatumumab
FDA Link
05/2015 - 04/2015
2
Interferons
IBA
01/2015 - 09/2012
2
purine
IBA
12/2014 - 04/2006
2
anandamide (arachidonylethanolamide)
IBA
01/2014 - 09/2008
2
SOXC Transcription Factors
IBA
01/2013 - 05/2012
2
Anti-Bacterial Agents (Antibiotics)
IBA
10/2007 - 09/2005
2
Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)
FDA Link
Generic
04/2006 - 08/2002
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
12/2023
1
Bortezomib (Velcade)
FDA Link
10/2023
1
Dexamethasone (Maxidex)
FDA Link
Generic
10/2023
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
10/2022
1
Surface Antigens (Surface Antigen)
IBA
10/2022
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
05/2021
1
Immunomodulating Agents
IBA
01/2020
1
Interleukin-2 (IL2)
IBA
01/2019
1
Chemokines
IBA
10/2018
1
23-valent pneumococcal capsular polysaccharide vaccine
IBA
01/2018
1
serum P-component (CIt)
IBA
01/2018
1
Indicators and Reagents (Reagents)
IBA
10/2017
1
obinutuzumab
IBA
02/2017
1
Genetic Markers (Genetic Marker)
IBA
01/2017
1
MicroRNAs (MicroRNA)
IBA
06/2014
1
ibritumomab tiuxetan (Zevalin)
FDA Link
05/2014
1
Etoposide (VP 16)
FDA Link
Generic
05/2014
1
Melphalan (Alkeran)
FDA Link
Generic
05/2014
1
Endocannabinoids
IBA
01/2014
1
Enzymes
IBA
01/2014
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
05/2012
1
Estrogen Receptors
IBA
01/2012
1
Therapeutic Uses
IBA
06/2011
1
Chromatin
IBA
11/2010
Therapy/Procedure
31
Therapeutics
07/2023 - 08/2002
17
Drug Therapy (Chemotherapy)
10/2023 - 11/2003
9
Stem Cell Transplantation
03/2017 - 11/2003
3
Immunotherapy
10/2019 - 05/2001
3
Hematopoietic Stem Cell Transplantation
12/2014 - 07/2013
2
Autologous Transplantation
08/2014 - 05/2013
2
Transplantation
05/2013 - 01/2004
2
Remission Induction
06/2010 - 11/2006
1
Immunomodulation
01/2020
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2018
1
Combination Drug Therapy (Combination Chemotherapy)
01/2017
1
Biological Therapy
09/2012